192 related articles for article (PubMed ID: 6463883)
1. [Natural cytotoxicity in systemic lupus erythematosus patients].
Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
[No Abstract] [Full Text] [Related]
2. [The significance of immuno-biologic parameters during and in the prognosis of patients with systemic lupus erythematosus].
Ljaljević M; Ljaljević J; Zlatković Lj; Latković J
Glas Srp Akad Nauka Med; 1982; (35):111-20. PubMed ID: 7182242
[No Abstract] [Full Text] [Related]
3. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
Tang HY
Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
[No Abstract] [Full Text] [Related]
4. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
Ewan PW; Barrett HM; Pusey CD
J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
[TBL] [Abstract][Full Text] [Related]
5. Effect of plasmapheresis in active systemic lupus erythematosus.
Kater L; Derksen RH; Houwert DA; Hené RJ; Struyvenberg A; Gmelig Meyling FH; Verroust P
Neth J Med; 1981; 24(6):209-16. PubMed ID: 7322246
[No Abstract] [Full Text] [Related]
6. Lupus erythematosus panniculitis (profundus).
Tuffanelli DL
Arch Dermatol; 1971 Mar; 103(3):231-42. PubMed ID: 4100949
[No Abstract] [Full Text] [Related]
7. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
[No Abstract] [Full Text] [Related]
8. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
Miller ML; Lantner R; Pachman LM
J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
[TBL] [Abstract][Full Text] [Related]
9. [Detection of circulating immune complexes in systemic lupus erythematosus by the method of conglutinin and monoclonal rheumatoid factor].
de Oliveira RM; Marchiori PE; Viana Vdos S; Bueno C; dos Reis M; Quevedo ME; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):6-9. PubMed ID: 4059787
[No Abstract] [Full Text] [Related]
10. [Characteristics of the immune complex process in patients with systemic lupus erythematosus with predominant kidney involvement].
Nasonov EL; Solov'ev SK; Sura VV; Ivanova MM; Poverennyĭ AM
Ter Arkh; 1986; 58(8):57-62. PubMed ID: 2945280
[No Abstract] [Full Text] [Related]
11. Impaired monocyte motility in sera from patients with systemic lupus erythematosus.
Sturfelt G; Linder C; Sjöholm AG; Svensson B
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):151-8. PubMed ID: 6880748
[TBL] [Abstract][Full Text] [Related]
12. [Detection of circulating immune complexes in patients with lupus erythematosus, viral hepatitis and rheumatoid arthritis using radioactive marked C1q].
Nydegger U; Lambert PH; Miescher PA
Verh Dtsch Ges Inn Med; 1974; 80():1575-7. PubMed ID: 4217986
[No Abstract] [Full Text] [Related]
13. Immunologic studies on systemic lupus erythematosus.
Shi SY; Kang KF; Weng MW; Tian RM; Hou AQ
Chin Med J (Engl); 1985 May; 98(5):336-42. PubMed ID: 3926405
[No Abstract] [Full Text] [Related]
14. [Serial studies of serum immune complexes and complements in patients with glomerulonephritis].
Nakayama S; Koide H; Ohno J
Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):163-9. PubMed ID: 6611432
[No Abstract] [Full Text] [Related]
15. [Systemic lupus erythematosus (SLE). I. New insights into serology and pathogenesis].
Feltkamp TE
Ned Tijdschr Geneeskd; 1974 Feb; 118(5):166-70. PubMed ID: 4596539
[No Abstract] [Full Text] [Related]
16. [Immunological and biochemical characteristics of circulating immune complexes in rheumatoid arthritis and systemic lupus erythematosus].
Venalis AI; Matulis AA; Mishkinite GA; Stankaĭtene DI
Ter Arkh; 1983; 55(7):24-8. PubMed ID: 6194570
[No Abstract] [Full Text] [Related]
17. Immunologic and other factors in thrombotic thrombocytopenic purpura (TTP).
Neame PB
Semin Thromb Hemost; 1980; 6(4):416-29. PubMed ID: 7013072
[No Abstract] [Full Text] [Related]
18. Plasmapheresis in systemic lupus erythematosus: effects on cellular immunity.
Vangelista A; Frascà GM; Nanni-Costa A; Bonomini V
Trans Am Soc Artif Intern Organs; 1983; 29():749-53. PubMed ID: 6608818
[No Abstract] [Full Text] [Related]
19. Some recent immunologic developments in the etiology and treatment of systemic lupus erythematosus.
Zweiman B; Courter AJ
Del Med J; 1975 Jun; 47(6):303-10. PubMed ID: 1095433
[No Abstract] [Full Text] [Related]
20. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
Oshimi K; Gonda N; Sumiya M; Kano S
Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
